Delivery Order SPE2DB22D7065-SPE2DB26FH0LT
- Not listed
- The Defense Logistics Agency awarded a $1,658.26 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,263.28 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed price, competitively awarded contract was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $18,509.94 under a firm fixed-price contract. This is a non-set-aside competitive award executed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $3,504.92 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Jardiance 10 mg tablets (90-count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is to be fulfilled at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,323.66 to AmerisourceBergen Drug Corp for 90-tablet supplies of Jardiance 25 mg, a diabetes management medication. The contract, issued August 6, 2025, with an ultimate completion date of August 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $60,686.92 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 29, 2025, with completion expected by September 30, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,172.97 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on August 29, 2025, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $51,975.23 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- SPE2DB22D7065Indefinite Delivery Contract
- SPE2DB22D7065-SPE2DB26FH0LTDelivery Order
The Defense Logistics Agency awarded a $1,606.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Jardiance, a diabetes management medication, exemplifies the type of pharmaceutical commodity AmerisourceBergen routinely supplies through its federal contract portfolio, which includes both brand-name and generic drugs supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/24/25 |